I-Anti-Estrogen Nolvadex (Tamoxifen Citrate) I-Powder Yokwakha Umzimba Ye-PCT CAS 10540-29-1
I-Tamoxifen Citrate(Nolvadex) Ukucaciswa
Elinye igama: Nolvadex
I-CAS: 10540-29-1
MF: C32H37NO8
MW: 563.64
Ukubukeka: impushana emhlophe ukuya emhlophe
Ukusetshenziswa: i-estrogen antagonist, i-antineoplastic
Ukusetshenziswa: Isetshenziselwa ukwelapha umdlavuza webele othuthukile, umdlavuza wesibeletho nawo uyasebenza, futhi imiphumela engcono ngeminye imithi elwa nomdlavuza
Ukupakisha: Njengezidingo zamakhasimende
Amagama angukhiye: Tamoxifen citrate, Tamoxifen citrate factory
I-Tamoxifen Citrate (Nolvadex) I-COA
| Izinto Zokuhlola | Ukucaciswa | Imiphumela Yokuhlola |
| Incazelo | I-crystalline powder emhlophe | I-crystalline powder emhlophe |
| Ukuhlonza | I-IR , i-UV ihambisana | Vumelanisa |
| Ukulahlekelwa ekomisweni | ≤0.5ml | 0.21ml |
| Izinsalela ekushiseni | Hhayi ngaphezu kuka-0.2% | 0.06ml |
| Insimbi | Hhayi ngaphezu kuka-0.005% | 0.0018% |
| Izinsimbi ezinzima | Hhayi ngaphezu kuka-0.001% | 0.0006% |
| Izinto ezihlobene | Ingqikithi: Hhayi ngaphezulu kuka-1.0% Umuntu ngamunye: Hhayi ngaphezu kuka-0.5% | 0.32% 0.14% |
| I-E-isomer | Hhayi ngaphezu kuka-0.3% | 0.19% |
| Ukungcola okuguquguqukayo kwe-Organic | Kuyavumelana | Kuyavumelana |
| Isivivinyo | 99.0~101.0% | 99.51% |
| Isiphetho | Vumelanisa ne-USP30 | |
I-Tamoxifen Citrate(Nolvadex) Incazelo
I-Nolvadex iyi-Selective Estrogen Receptor Modulator (SERM) edumile futhi esebenza ngamandla evame ukubizwa ngokuthi i-anti-estrogen.Kodwa-ke, ngenkathi i-antagonist iphinde ibe i-agonist njengoba izosebenza njenge-estrogen ezingxenyeni ezithile zomzimba ngenkathi isebenza njenge-anti-estrogen kwezinye izindawo.Njengenye ye-SERM endala kakhulu emakethe esasetshenziswa njalo ekwelapheni, kuyilapho i-Nolvadex iphinde isetshenziswe abasebenzisi be-anabolic steroid akuyona i-anabolicsteroid.Leli inothi elibalulekile njengoba abanye bevame ukudideka ngokusetshenziswa kwayo emijikelezweni ye-steroid.I-Nolvadex imane nje iyi-SERM.
I-Nolvadex, eyaziwa ngokusemthethweni ngokuthi i-Tamoxifen Citrate, yaqala ukuthuthukiswa ngo-1961 yi-ICI manje eyi-AstraZeneca ngaphansi kwegama lokuhweba elithi Nolvadex.I-SERM yenzelwe ukwelapha umdlavuza webele, ikakhulukazi umdlavuza webele osabela ngehomoni.Kodwa-ke, iye yasetshenziswa ngokuphumelelayo ekuvimbeleni umdlavuza webele.Khona-ke sinabasebenzisi be-anabolic steroid, futhi kudala kwatholakala ukuthi i-Nolvadex inendawo phakathi kwabantu abanjalo.I-Nolva, njengoba ivame ukwaziwa, ingasetshenziswa njenge-anti-estrogen phakathi nomjikelezo we-anabolic steroid ukuze kuvinjelwe imiphumela emibi ehlobene ne-estrogenic.Iphinde isetshenziswe njengengxenye yohlelo lokubuyisela i-Post Cycle Therapy (PCT), okuyiphuzu layo elivame kakhulu nelizuzisa kakhulu elisetshenziswa umsebenzisi we-steroid.
Ukupakisha Nokulethwa
